Home » Topics » Regulatory » Patents

Patents
RSS

Cor Therapeutics describes selective factor Xa inhibitors

July 8, 1998

PDE V inhibitors for heart failure, impotence claimed by Merck KGaA

July 8, 1998

Investigation at Kowa results in development of potent CysLT1 receptor antagonists

July 7, 1998

Series of MMP and TACE inhibitors patented by American Cyanamid

July 7, 1998

ACAT inhibitors from SS Pharm. for atherosclerosis

July 7, 1998

Taisho claims potent and selective D4 receptor antagonists

July 7, 1998

Carcinostatic agents developed at Toagosei

July 7, 1998

Novel antitumor agent discovered by Banyu

July 7, 1998

HIV protease inhibitors developed by research group at Sankyo

July 7, 1998

Toyama describes novel cephalosporins for oral administration

July 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...